HEAL Stock Overview
Operates a network of general hospitals in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
PT Medikaloka Hermina Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp1,415.00 |
| 52 Week High | Rp1,640.00 |
| 52 Week Low | Rp1,060.00 |
| Beta | 0.51 |
| 1 Month Change | 0.35% |
| 3 Month Change | -2.75% |
| 1 Year Change | -4.07% |
| 3 Year Change | 41.50% |
| 5 Year Change | 94.37% |
| Change since IPO | 123.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| HEAL | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | -3.7% | -2.4% | -3.6% |
| 1Y | -4.1% | 17.3% | 2.7% |
Return vs Industry: HEAL underperformed the ID Healthcare industry which returned 17.3% over the past year.
Return vs Market: HEAL underperformed the ID Market which returned 2.7% over the past year.
Price Volatility
| HEAL volatility | |
|---|---|
| HEAL Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in ID Market | 12.8% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: HEAL has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: HEAL's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 18,231 | H. Hasmoro | www.herminahospitals.com |
PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of general hospitals in Indonesia. The company offers services in anatomical pathology, andrology, anesthesiology, aviation specialist, cardiology, clinical microbiology, clinical nutrition, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology, nuclear medicine and molecular theranostics, obstetrics and gynaecology, occupational, and occupational therapy. Its services also include ophthalmology, orthopedic surgery, otorhinolaryngology, pediatric neurology, pediatrics, physical medicine and rehabilitation, plastic and reconstructive surgery, psychiatry, psychology, pulmonology, radiation oncology, radiology, sports specialist, surgery, and urology.
PT Medikaloka Hermina Tbk Fundamentals Summary
| HEAL fundamental statistics | |
|---|---|
| Market cap | Rp21.07t |
| Earnings (TTM) | Rp556.67b |
| Revenue (TTM) | Rp6.58t |
37.8x
P/E Ratio3.2x
P/S RatioIs HEAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HEAL income statement (TTM) | |
|---|---|
| Revenue | Rp6.58t |
| Cost of Revenue | Rp4.31t |
| Gross Profit | Rp2.27t |
| Other Expenses | Rp1.72t |
| Earnings | Rp556.67b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 37.39 |
| Gross Margin | 34.56% |
| Net Profit Margin | 8.46% |
| Debt/Equity Ratio | 52.3% |
How did HEAL perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield23%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 22:12 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PT Medikaloka Hermina Tbk is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Patricia Gabriela | CGS International |
| Jason Chandra | CGS International |
| Lakshmi Rowter | Citigroup Inc |